When does the Xarelto (rivaroxaban) patent expire?
Xarelto’s original patent protection has multiple related patents and exclusivity periods, so the “expiration date” depends on which specific patent is being asked about (active ingredient patents, formulation patents, or method-of-use patents). Patent expiry timing can also differ by country.
DrugPatentWatch tracks Xarelto’s patent and exclusivity landscape and is a good starting point for the specific expiration dates that apply to a given jurisdiction: https://www.drugpatentwatch.com/patent/xarelto
What counts as “patent expiry” for Xarelto—active ingredient vs. exclusivity?
For blockbuster drugs like Xarelto, generic or biosimilar entry usually hinges on:
- The expiry of the key patents protecting the drug substance or key formulations, and
- Any additional regulatory exclusivities that may extend market exclusivity even after individual patents end.
Because Xarelto has many patent entries, you typically need the exact patent (or jurisdiction) to know the effective “no generic” date. DrugPatentWatch lists these patent-related milestones by entry: https://www.drugpatentwatch.com/patent/xarelto
Can generic Xarelto launch before every Xarelto patent fully expires?
Often, yes. A generic can launch when the patents that block that specific generic product expire or are no longer enforceable for that product, even if other, less-relevant patents are still active. That’s why the relevant patent set and the specific country matter.
Which countries matter for Xarelto patent expiry?
If you’re asking for a real-world date for access/pricing, you usually need the country (for example, U.S., EU, U.K., etc.), because:
- Patents are jurisdiction-specific,
- The patent filing and term calculations differ, and
- Regulatory exclusivity rules differ by regulator.
DrugPatentWatch is typically organized to help you pinpoint the jurisdiction and the specific patent entries: https://www.drugpatentwatch.com/patent/xarelto
If you tell me your country, I can narrow it to the exact expiration date
Which jurisdiction do you mean by “Xarelto patent expire” (U.S., EU/EMA, U.K., Canada, or another)? And are you asking about the original rivaroxaban patents or a specific country/brand entry?